Madhi SA - Search Results

1

Estimating the burden of iron deficiency among African children.

Muriuki JM, Mentzer AJ, Webb EL, Morovat A, Kimita W, Ndungu FM, Macharia AW, Crane RJ, Berkley JA, Lule SA, Cutland C, Sirima SB, Diarra A, Tiono AB, Bejon P, Madhi SA, Hill AVS, Prentice AM, Suchdev PS, Elliott AM, Williams TN, Atkinson SH. Muriuki JM, et al. Among authors: madhi sa. BMC Med. 2020 Feb 27;18(1):31. doi: 10.1186/s12916-020-1502-7. BMC Med. 2020. PMID: 32102669 Free PMC article.

2

Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia.

Madhi SA, Cutland C, Ismail K, O'Reilly C, Mancha A, Klugman KP. Madhi SA, et al. Clin Infect Dis. 2002 Nov 1;35(9):1120-6. doi: 10.1086/343049. Epub 2002 Oct 7. Clin Infect Dis. 2002. PMID: 12384847

3

Importance of nosocomial respiratory syncytial virus infections in an African setting.

Madhi SA, Ismail K, O'Reilly C, Cutland C. Madhi SA, et al. Trop Med Int Health. 2004 Apr;9(4):491-8. doi: 10.1111/j.1365-3156.2004.01221.x. Trop Med Int Health. 2004. PMID: 15078268 Free article.

4

The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV-infected and -uninfected children.

Madhi SA, Kuwanda L, Cutland C, Klugman KP. Madhi SA, et al. Clin Infect Dis. 2005 May 15;40(10):1511-8. doi: 10.1086/429828. Epub 2005 Apr 7. Clin Infect Dis. 2005. PMID: 15844075 Clinical Trial.

5

Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African human immunodeficiency virus-infected and uninfected children.

Madhi SA, Kuwanda L, Cutland C, Holm A, Käyhty H, Klugman KP. Madhi SA, et al. Pediatr Infect Dis J. 2005 May;24(5):410-6. doi: 10.1097/01.inf.0000160942.84169.14. Pediatr Infect Dis J. 2005. PMID: 15876939 Clinical Trial.

6

Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children.

Madhi SA, Kuwanda L, Saarinen L, Cutland C, Mothupi R, Käyhty H, Klugman KP. Madhi SA, et al. Vaccine. 2005 Dec 1;23(48-49):5517-25. doi: 10.1016/j.vaccine.2005.07.038. Epub 2005 Aug 1. Vaccine. 2005. PMID: 16107294

7

Usefulness of C-reactive protein to define pneumococcal conjugate vaccine efficacy in the prevention of pneumonia.

Madhi SA, Kohler M, Kuwanda L, Cutland C, Klugman KP. Madhi SA, et al. Pediatr Infect Dis J. 2006 Jan;25(1):30-6. doi: 10.1097/01.inf.0000195787.99199.4a. Pediatr Infect Dis J. 2006. PMID: 16395099 Clinical Trial.

8

Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers.

Madhi SA, Cutland C, Zhu Y, Hackell JG, Newman F, Blackburn N, Murphy BR, Belshe RB, Karron RA, Deatly AM, Gruber WC, Bernstein DI, Wright PF. Madhi SA, et al. Vaccine. 2006 Mar 20;24(13):2432-9. doi: 10.1016/j.vaccine.2005.12.002. Epub 2005 Dec 20. Vaccine. 2006. PMID: 16406170 Clinical Trial.

9

Pneumococcal coinfection with human metapneumovirus.

Madhi SA, Ludewick H, Kuwanda L, Niekerk Nv, Cutland C, Little T, Klugman KP. Madhi SA, et al. J Infect Dis. 2006 May 1;193(9):1236-43. doi: 10.1086/503053. Epub 2006 Mar 17. J Infect Dis. 2006. PMID: 16586360 Clinical Trial.

10

Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children.

Madhi SA, Kuwanda L, Cutland C, Klugman KP. Madhi SA, et al. J Clin Virol. 2006 Jul;36(3):215-21. doi: 10.1016/j.jcv.2006.03.010. Epub 2006 May 5. J Clin Virol. 2006. PMID: 16678480 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

679 results

Search Page